ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Four-Year Results: The EVOLUT Low Risk Trial"
Episode Synopsis
Michael J. Reardon and C. Michael Gibson discuss the trial's 4-year results in low-surgical-risk patients with severe aortic stenosis randomized to self-expanding TAVI or SAVR.
More episodes of the podcast Talking Points
The 2024 ESC CCS Guidelines
17/12/2025
The My Heart Your Heart Trial
10/12/2025
The FAVOR III Europe Trial
03/12/2025
The FLOW Trial
03/12/2025
STORM-PE TRIAL
19/11/2025
The EARLY TAVR and TAVR UNLOAD Trials
12/11/2025
The EPIC-CAD Trial
29/10/2025
The ECLIPSE Trial
01/10/2025
The CLEAR SYNERGY (OASIS 9) Trial
17/09/2025
The NOTION-3 Trial
03/09/2025
In God we trust